242 related articles for article (PubMed ID: 17547070)
21. Influenza vaccination among the elderly Spanish population: trend from 1993 to 2003 and vaccination-related factors.
de Andres AL; Garrido PC; Hernández-Barrera V; Del Pozo SV; de Miguel AG; Jiménez-García R
Eur J Public Health; 2007 Jun; 17(3):272-7. PubMed ID: 17071634
[TBL] [Abstract][Full Text] [Related]
22. Reducing major cause-specific hospitalization rates and shortening hospital stays after influenza vaccination.
Wang CS; Wang ST; Lai CT; Lin LJ; Lee CT; Chou P
Clin Infect Dis; 2004 Dec; 39(11):1604-10. PubMed ID: 15578359
[TBL] [Abstract][Full Text] [Related]
23. Retrospective assessment of influenza vaccine effectiveness among the non-institutionalized elderly population in Japan.
Ozasa K; Kawahito Y; Doi T; Watanabe Y; Washio M; Mori M; Kase T; Maeda A; Hirota Y
Vaccine; 2006 Mar; 24(14):2537-43. PubMed ID: 16417955
[TBL] [Abstract][Full Text] [Related]
24. Clinical impact of influenza immunization in patients with liver cirrhosis.
Song JY; Cheong HJ; Ha SH; Hwang IS; Kee SY; Jeong HW; Lee CG; Kim WJ
J Clin Virol; 2007 Jul; 39(3):159-63. PubMed ID: 17560166
[TBL] [Abstract][Full Text] [Related]
25. Effect of influenza vaccine status on winter mortality in Spanish community-dwelling elderly people during 2002-2005 influenza periods.
Vila-Córcoles A; Rodriguez T; de Diego C; Ochoa O; Valdivieso A; Salsench E; Ansa X; Badía W; Saún N;
Vaccine; 2007 Sep; 25(37-38):6699-707. PubMed ID: 17698263
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
27. Influenza like Illness (ILI): prescribing behaviour of 83 sentry doctors in Lazio region in the period 2001-2002. Is it adherent to Italian ILI guidelines?
Orzella L; Perria C; Jefferson T; Pasquarella A; D'Amato M; Faraone M; Volpe E; Guasticchi G
Ann Ig; 2007; 19(1):19-26. PubMed ID: 17405509
[TBL] [Abstract][Full Text] [Related]
28. Factors affecting the influenza vaccination of high risk adults in Hawai'i.
Davis JW; Fujimoto RY; Chan H; Juarez DT
Hawaii Med J; 2009 Apr; 68(3):50-4. PubMed ID: 19441613
[TBL] [Abstract][Full Text] [Related]
29. Immunomodulating effect of influenza vaccination in the elderly differing in health status.
Myśliwska J; Trzonkowski P; Szmit E; Brydak LB; Machała M; Myśliwski A
Exp Gerontol; 2004 Oct; 39(10):1447-58. PubMed ID: 15501014
[TBL] [Abstract][Full Text] [Related]
30. [Coverage rates of influenza vaccine in Italy during the 2002/3 and 2003/04 seasons: a cross-sectional study].
Müller D; Szucs TD
Ann Ig; 2005; 17(4):351-63. PubMed ID: 16156395
[TBL] [Abstract][Full Text] [Related]
31. Influenza-like illness in residential care homes: a study of the incidence, aetiological agents, natural history and health resource utilisation.
Hui DS; Woo J; Hui E; Foo A; Ip M; To KW; Cheuk ES; Lam WY; Sham A; Chan PK
Thorax; 2008 Aug; 63(8):690-7. PubMed ID: 18250183
[TBL] [Abstract][Full Text] [Related]
32. Clinical effectiveness of influenza vaccination in persons younger than 65 years with high-risk medical conditions: the PRISMA study.
Hak E; Buskens E; van Essen GA; de Bakker DH; Grobbee DE; Tacken MA; van Hout BA; Verheij TJ
Arch Intern Med; 2005 Feb; 165(3):274-80. PubMed ID: 15710789
[TBL] [Abstract][Full Text] [Related]
33. Quantifying the potential role of unmeasured confounders: the example of influenza vaccination.
Groenwold RH; Hoes AW; Nichol KL; Hak E
Int J Epidemiol; 2008 Dec; 37(6):1422-9. PubMed ID: 18725358
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and predictors of influenza vaccination among frail, community-living elderly patients: an international observational study.
Landi F; Onder G; Carpenter I; Garms-Homolova V; Bernabei R
Vaccine; 2005 Jun; 23(30):3896-901. PubMed ID: 15917110
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of a mass influenza vaccination campaign.
Takahashi H; Tanaka Y; Ohyama T; Sunagawa T; Nakashima K; Schmid GP; Okabe N
Jpn J Infect Dis; 2001 Oct; 54(5):184-8. PubMed ID: 11754156
[TBL] [Abstract][Full Text] [Related]
36. Effectiveness of vaccination against influenza in SkodaAuto Company employees during the influenza season 2000-2001.
Beran J; Moravík J
Cent Eur J Public Health; 2003 Dec; 11(4):209-12. PubMed ID: 14768784
[TBL] [Abstract][Full Text] [Related]
37. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.
Zhu FC; Zhou W; Pan H; Lu L; Gerez L; Nauta J; Giezeman K; de Bruijn I
Vaccine; 2008 Aug; 26(35):4579-84. PubMed ID: 18602729
[TBL] [Abstract][Full Text] [Related]
38. In a prospective observational study, influenza vaccination prevented hospitalization among older home care patients.
Landi F; Onder G; Cesari M; Russo A; Barillaro C; Bernabei R; ; Gambassi G; Manigrasso L; Pagano F; Gobbi C
J Clin Epidemiol; 2006 Oct; 59(10):1072-7. PubMed ID: 16980147
[TBL] [Abstract][Full Text] [Related]
39. Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season.
Fujieda M; Maeda A; Kondo K; Kaji M; Hirota Y
Vaccine; 2006 Feb; 24(7):957-63. PubMed ID: 16171903
[TBL] [Abstract][Full Text] [Related]
40. Do recommended high-risk adults benefit from a first influenza vaccination?
Hak E; Buskens E; Nichol KL; Verheij TJ
Vaccine; 2006 Apr; 24(15):2799-802. PubMed ID: 16480796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
